Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > Ispinesib

Ispinesib

Ispinesib structure

Ispinesib 

structure
  • CAS No:

    336113-53-2

  • Formula:

    C30H33ClN4O2

  • Chemical Name:

    Ispinesib

  • Synonyms:

    Ispinesib;N-(3-Aminopropyl)-N-[(1R)-1-[7-chloro-3,4-dihydro-4-oxo-3-(phenylmethyl)-2-quinazolinyl]-2-methylpropyl]-4-methylbenzamide;SB 715992;Benzamide, N-(3-aminopropyl)-N-((1R)-1-(7-chloro-3,4-dihydro-4-oxo-3-(phenylmethyl)-2-quinazolinyl)-2-methylpropyl)-4-methyl-;Unii-bkt5F9C2ni;Ispinesib2;SB-71599;Ispinesib (SB-715992 /CK0238273)

  • Categories:

    Biochemical Engineering  >  Inhibitors

Description

Ispinesib is a specific inhibitor of KSP, with a Ki app of 1.7 nM.

Ispinesib Basic Attributes

517.08

516.229187

Characteristics

79

5.3

1.2±0.1 g/cm3

707.986°C at 760 mmHg

382.0±35.7 °C

1.619

Ispinesib Use and Manufacturing

The kinesin-like spindle protein Eg5 (also known as kinesin-5, kinesin family protein 11, or Kif11) is a motor protein that is essential for establishing a bipolar spindle during mitosis both in normal and tumor cells. Ispinesib is a cell-permeable, allosteric inhibitor of Eg5 (Ki app = 2.3 nM) with >10,000-fold selectivity for Eg5 over a range of other mitotic kinesins. It induces a monopolar spindle phenotype, leading to the activation of a spindle assembly checkpoint, mitotic arrest, and subsequent cell death (GI50s = 22-82 nM in colon, pancreas, prostrate, and lung cancer cells in vitro). At 10 mg/kg, ispinesib produces tumor regression of breast cancer cell xenografts in mice. It has also been used to halt the growth of treatment-resistant glioblastoma tumor-initiating cells, to prevent tumor initiation and self-renewal of a cancer stem cell population (EC50 = 1.15 nM), and to reduce glioma cell invasion.[Cayman Chemical]

Recommended Suppliers of Ispinesib

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.